Metabolic endotoxemia with obesity: Is it real and is it relevant?

Biochimie

Volumn 124, Issue , 2016, Pages 11-20

  Boutagy, Nabil E ^a   McMillan, Ryan P ^a   Frisard, Madlyn I ^a   Hulver, Matthew W ^a  

^a VIRGINIA POLYTECHNIC INSTITUTE AND STATE UNIVERSITY   (United States)

Author keywords

Endotoxin detection; Inflammation; Metabolic endotoxemia; Obesity; Substrate metabolism

Indexed keywords

DISEASE ASSOCIATION; ENDOTOXEMIA; ENDOTOXIN DETECTION; FAT INTAKE; FATTY ACID OXIDATION; GLUCOSE INTOLERANCE; GLUCOSE OXIDATION; HUMAN; INSULIN RESISTANCE; INTESTINE FLORA; LIPID DIET; LIPID STORAGE; METABOLIC DISORDER; METABOLIC SYNDROME X; MICROBIAL COMMUNITY; MUSCLE METABOLISM; NONHUMAN; OBESITY; OXYGEN CONSUMPTION; REVIEW; SKELETAL MUSCLE; WEIGHT REDUCTION; ANIMAL; BLOOD; COMPLICATION; INFLAMMATION; INTESTINE; METABOLISM; OXIDATIVE STRESS; PATHOLOGY;

LIPOPOLYSACCHARIDE; TLR4 PROTEIN, HUMAN; TOLL LIKE RECEPTOR 4;

ANIMALS; ENDOTOXEMIA; HUMANS; INFLAMMATION; INTESTINES; LIPOPOLYSACCHARIDES; OBESITY; OXIDATIVE STRESS; TOLL-LIKE RECEPTOR 4;

EID: 84935519654     PISSN: 03009084     EISSN: 61831638     Source Type: Journal    
DOI: 10.1016/j.biochi.2015.06.020     Document Type: Review

References (105)

1. J.C. Hurley Endotoxemia: methods of detection and clinical correlates Clin. Microbiol. Rev. 8 1995 268 292
2. C.R. Raetz, and C. Whitfield Lipopolysaccharide endotoxins Annu. Rev. Biochem. 71 2002 635 700
3. S. Ghoshal, J. Witta, J. Zhong, W. de Villiers, and E. Eckhardt Chylomicrons promote intestinal absorption of lipopolysaccharides J. Lipid Res. 50 2009 90 97
4. P.D. Cani, J. Amar, M.A. Iglesias, M. Poggi, C. Knauf, D. Bastelica, A.M. Neyrinck, F. Fava, K.M. Tuohy, and C. Chabo Metabolic endotoxemia initiates obesity and insulin resistance Diabetes 56 2007 1761 1772
5. D.D. Bannerman, and S.E. Goldblum Direct effects of endotoxin on the endothelium: barrier function and injury Lab. Invest. A J. Tech. Methods Pathol. 79 1999 1181
6. Y.C. Lu, W.C. Yeh, and P.S. Ohashi Lps/tlr4 signal transduction pathway Cytokine 42 2008 145 151
7. K. Asehnoune, D. Strassheim, S. Mitra, J.Y. Kim, and E. Abraham Involvement of reactive oxygen species in toll-like receptor 4-dependent activation of nf-kappa b J. Immunol. (Baltimore, Md.: 1950) 172 2004 2522 2529
8. K.A. Ryan, M.F. Smith Jr., M.K. Sanders, and P.B. Ernst Reactive oxygen and nitrogen species differentially regulate toll-like receptor 4-mediated activation of nf-kappa b and interleukin-8 expression Infect. Immun. 72 2004 2123 2130
9. R.A. Frost, G.J. Nystrom, and C.H. Lang Lipopolysaccharide regulates proinflammatory cytokine expression in mouse myoblasts and skeletal muscle Am. J. Physiol. Regul. Integr. Comp. Physiol. 283 2002 R698 R709
10. T. Gustot, A. Lemmers, C. Moreno, N. Nagy, E. Quertinmont, C. Nicaise, D. Franchimont, H. Louis, J. Deviere, and O. Le Moine Differential liver sensitization to toll-like receptor pathways in mice with alcoholic fatty liver Hepatol. (Baltimore, Md.) 43 2006 989 1000
11. M.J. Song, K.H. Kim, J.M. Yoon, and J.B. Kim Activation of toll-like receptor 4 is associated with insulin resistance in adipocytes Biochem. Biophys. Res. Commun. 346 2006 739 745
12. R.C. Bone The sepsis syndrome: definition and general approach to management Clin. Chest Med. 17 1996 175 181
13. J.K. McCormick, J.M. Yarwood, and P.M. Schlievert Toxic shock syndrome and bacterial superantigens: an update Annu. Rev. Microbiol. 55 2001 77 104
14. S.M. Opal, P.J. Scannon, J.L. Vincent, M. White, S.F. Carroll, J.E. Palardy, N.A. Parejo, J.P. Pribble, and J.H. Lemke Relationship between plasma levels of lipopolysaccharide (lps) and lps-binding protein in patients with severe sepsis and septic shock J. Infect. Dis. 180 1999 1584 1589
15. J.L. Ding, and B. Ho Endotoxin Detection-from Limulus Amebocyte Lysate to Recombinant Factor c. Endotoxins: Structure, Function and Recognition 2010 Springer 187 208
16. P.D. Cani, R. Bibiloni, C. Knauf, A. Waget, A.M. Neyrinck, N.M. Delzenne, and R. Burcelin Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice Diabetes 57 2008 1470 1481
17. C.L. Ogden, M.D. Carroll, L.R. Curtin, M.A. McDowell, C.J. Tabak, and K.M. Flegal Prevalence of overweight and obesity in the united states, 1999-2004 JAMA 295 2006 1549 1555
18. Organization WH Obesity: Preventing and Managing the Global Epidemic: Report of a Who Consultation on Obesity 1998 World health organization Geneva, switzerland Publication no. World Health Organ Tech Rep Ser.894
19. M.F. Gregor, and G.S. Hotamisligil Inflammatory mechanisms in obesity Annu Rev. Immunol. 29 2011 415 445
20. P. Dandona, A. Aljada, and A. Bandyopadhyay Inflammation: the link between insulin resistance, obesity and diabetes Trends Immunol. 25 2004 4 7
21. L.F. Van Gaal, I.L. Mertens, and E. Christophe Mechanisms linking obesity with cardiovascular disease Nature 444 2006 875 880
22. Control CfD, Prevention National Diabetes Statistics Report: Estimates of Diabetes and its Burden in the United States 2014 US Department of Health and Human Services Atlanta, GA
23. D. Mozaffarian, E.J. Benjamin, A.S. Go, D.K. Arnett, M.J. Blaha, M. Cushman, S. de Ferranti, J. Despres, H.J. Fullerton, V.J. Howard, M.D. Huffman, S.E. Judd, B.M. Kissela, D.T. Lackland, J.H. Lichtman, L.D. Lisabeth, S. Liu, R.H. Mackey, D.B. Matchar, D.K. McGuire, E.R. Mohler 3rd, C.S. Moy, P. Muntner, M.E. Mussolino, K. Nasir, R.W. Neumar, G. Nichol, L. Palaniappan, D.K. Pandey, M.J. Reeves, C.J. Rodriguez, P.D. Sorlie, J. Stein, A. Towfighi, T.N. Turan, S.S. Virani, J.Z. Willey, D. Woo, R.W. Yeh, and M.B. Turner Heart disease and stroke statistics-2015 update: A report from the american heart association Circulation 131 4 2015 e29 e322
24. V.G. DeMarco, M.S. Johnson, A.T. Whaley-Connell, and J.R. Sowers Cytokine abnormalities in the etiology of the cardiometabolic syndrome Curr. Hypertens. Reports 12 2010 93 98
25. K.E. Kallio, K.A. Hätönen, M. Lehto, V. Salomaa, S. Männistö, and P.J. Pussinen Endotoxemia, nutrition, and cardiometabolic disorders Acta Diabetol. 2014 1 10
26. M.I. Lassenius, K.H. Pietilainen, K. Kaartinen, P.J. Pussinen, J. Syrjanen, C. Forsblom, I. Porsti, A. Rissanen, J. Kaprio, J. Mustonen, P.H. Groop, and M. Lehto Bacterial endotoxin activity in human serum is associated with dyslipidemia, insulin resistance, obesity, and chronic inflammation Diabetes Care 34 2011 1809 1815
27. S.V. Monte, J.A. Caruana, H. Ghanim, C.L. Sia, K. Korzeniewski, J.J. Schentag, and P. Dandona Reduction in endotoxemia, oxidative and inflammatory stress, and insulin resistance after roux-en-y gastric bypass surgery in patients with morbid obesity and type 2 diabetes mellitus Surgery 151 2012 587 593
28. I.T. Zeckwer, and H. Goodell Blood sugar studies: II. Blood sugar changes in fatal bacterial anaphylaxis in the rabbit J. Exp. Med. 42 1925 57 67
29. M. Delafield A comparison of the changes in the blood sugar and blood phosphorus in rabbits following the injection of suspensions of different dead bacteria J. Pathology Bacteriol. 35 1932 53 68
30. K.F. LaNoue, A.D. Mason, and J.P. Daniels The impairment of glucogenesis by gram negative infection Metabolism 17 1968 606 611
31. L. Berry, and D. Smithe Effects of bacterial endotoxins on metabolism. VII. Enzyme induction as a protective mechanism against endotoxin toxicity J. Exp. Med 120 5 1964 721 732
32. J.J. Spitzer, G.J. Bagby, K. Meszaros, and C.H. Lang Altered control of carbohydrate metabolism in endotoxemia Prog. Clin. Biol. Res. 286 1988 145 165
33. H. Tavakoli, and L. Mela Alterations of mitochondrial metabolism and protein concentrations in subacute septicemia Infect. Immun. 38 1982 536 541
34. J. Amar, R. Burcelin, J.B. Ruidavets, P.D. Cani, J. Fauvel, M.C. Alessi, B. Chamontin, and J. Ferriéres Energy intake is associated with endotoxemia in apparently healthy men Am. J. Clin. Nutr. 87 2008 1219 1223
35. P.D. Cani, S. Possemiers, T. Van de Wiele, Y. Guiot, A. Everard, O. Rottier, L. Geurts, D. Naslain, A. Neyrinck, D.M. Lambert, G.G. Muccioli, and N.M. Delzenne Changes in gut microbiota control inflammation in obese mice through a mechanism involving glp-2-driven improvement of gut permeability Gut 58 2009 1091 1103
36. G.G. Muccioli, D. Naslain, F. Backhed, C.S. Reigstad, D.M. Lambert, N.M. Delzenne, and P.D. Cani The endocannabinoid system links gut microbiota to adipogenesis Mol. Syst. Biol. 6 2010 392
37. A.R. Saltiel, and C.R. Kahn Insulin signalling and the regulation of glucose and lipid metabolism Nature 414 2001 799 806
38. Y. Wei, K. Chen, A.T. Whaley-Connell, C.S. Stump, J.A. Ibdah, and J.R. Sowers Skeletal muscle insulin resistance: role of inflammatory cytokines and reactive oxygen species Am. J. Physiology-Regulatory, Integr. Comp. Physiol. 294 2008 R673 R680
39. G.S. Hotamisligil Inflammation and metabolic disorders Nature 444 2006 860 867
40. K. Ando, and T. Fujita Metabolic syndrome and oxidative stress Free Radic. Biol. Med. 47 2009 213 218
41. M.I. Frisard, R.P. McMillan, J. Marchand, K.A. Wahlberg, Y. Wu, K.A. Voelker, L. Heilbronn, K. Haynie, B. Muoio, L. Li, and M.W. Hulver Toll-like receptor 4 modulates skeletal muscle substrate metabolism Am. J. Physiol. Endocrinol. Metab. 298 2010 23
42. M.I. Frisard, Y. Wu, R.P. McMillan, K.A. Voelker, K.A. Wahlberg, A.S. Anderson, N. Boutagy, K. Resendes, E. Ravussin, and M.W. Hulver Low levels of lipopolysaccharide modulate mitochondrial oxygen consumption in skeletal muscle Metabolism 64 2015 416 427
43. H.S. Park, H.Y. Jung, E.Y. Park, J. Kim, W.J. Lee, and Y.S. Bae Cutting edge: direct interaction of tlr4 with nad (p) h oxidase 4 isozyme is essential for lipopolysaccharide-induced production of reactive oxygen species and activation of nf-κb J. Immunol. 173 2004 3589 3593
44. G. Gloire, S. Legrand-Poels, and J. Piette Nf-kappab activation by reactive oxygen species: fifteen years later Biochem. Pharmacol. 72 2006 1493 1505
45. B. Haimovich, Z. Zhang, J.E. Calvano, S.E. Calvano, A. Kumar, M.A. Macor, S. Corbett, S.M. Coyle, and S.F. Lowry Cellular metabolic regulators: novel indicators of low-grade inflammation in humans Ann. Surg. 259 2014 999 1006
46. M. Maachi, L. Pieroni, E. Bruckert, C. Jardel, S. Fellahi, B. Hainque, J. Capeau, and J. Bastard Systemic low-grade inflammation is related to both circulating and adipose tissue tnfα, leptin and il-6 levels in obese women Int. J. Obes. 28 2004 993 997
47. M.F. Gregor, and G.S. Hotamisligil Inflammatory mechanisms in obesity Annu. Rev. Immunol. 29 2011 415 445
48. S.J. Creely, P.G. McTernan, C.M. Kusminski, N. Da Silva, M. Khanolkar, M. Evans, A. Harte, and S. Kumar Lipopolysaccharide activates an innate immune system response in human adipose tissue in obesity and type 2 diabetes Am. J. Physiology-Endocrinol. Metabolism 292 2007 E740 E747
49. S.M. Reyna, S. Ghosh, P. Tantiwong, C.R. Meka, P. Eagan, C.P. Jenkinson, E. Cersosimo, R.A. DeFronzo, D.K. Coletta, and A. Sriwijitkamol Elevated toll-like receptor 4 expression and signaling in muscle from insulin-resistant subjects Diabetes 57 2008 2595 2602
50. S. Basu, M. Haghiac, P. Surace, J.C. Challier, M. Guerre-Millo, K. Singh, T. Waters, J. Minium, L. Presley, and P.M. Catalano Pregravid obesity associates with increased maternal endotoxemia and metabolic inflammation Obesity 19 2011 476 482
51. R.E. Ley, P.J. Turnbaugh, S. Klein, and J.I. Gordon Microbial ecology: human gut microbes associated with obesity Nature 444 2006 1022
52. A. Schwiertz, D. Taras, K. Schäfer, S. Beijer, N.A. Bos, C. Donus, and P.D. Hardt Microbiota and scfa in lean and overweight healthy subjects Obesity 18 2010 190 195
53. H. Zhang, J.K. DiBaise, A. Zuccolo, D. Kudrna, M. Braidotti, Y. Yu, P. Parameswaran, M.D. Crowell, R. Wing, and B.E. Rittmann Human gut microbiota in obesity and after gastric bypass Proc. Natl. Acad. Sci. 106 2009 2365 2370
54. P.J. Turnbaugh, M. Hamady, T. Yatsunenko, B.L. Cantarel, A. Duncan, R.E. Ley, M.L. Sogin, W.J. Jones, B.A. Roe, and J.P. Affourtit A core gut microbiome in obese and lean twins Nature 457 2009 480 484
55. M. Million, M. Maraninchi, M. Henry, F. Armougom, H. Richet, P. Carrieri, R. Valero, D. Raccah, B. Vialettes, and D. Raoult Obesity-associated gut microbiota is enriched in lactobacillus reuteri and depleted in bifidobacterium animalis and methanobrevibacter smithii Int. J. Obes. 36 2012 817 825
56. M. Kalliomäki, M.C. Collado, S. Salminen, and E. Isolauri Early differences in fecal microbiota composition in children may predict overweight Am. J. Clin. Nutr. 87 2008 534 538
57. A. Santacruz, M.C. Collado, L. Garcia-Valdes, M.T. Segura, J.A. Martin-Lagos, T. Anjos, M. Marti-Romero, R.M. Lopez, J. Florido, C. Campoy, and Y. Sanz Gut microbiota composition is associated with body weight, weight gain and biochemical parameters in pregnant women Br. J. Nutr. 104 2010 83 92
58. E.A. Griffiths, L.C. Duffy, F.L. Schanbacher, H. Qiao, D. Dryja, A. Leavens, J. Rossman, G. Rich, D. Dirienzo, and P.L. Ogra In vivo effects of bifidobacteria and lactoferrin on gut endotoxin concentration and mucosal immunity in balb/c mice Dig. Dis. Sci. 49 2004 579 589
59. Z. Wang, G. Xiao, Y. Yao, S. Guo, K. Lu, and Z. Sheng The role of bifidobacteria in gut barrier function after thermal injury in rats J. Trauma 61 2006 650 657
60. C. Erridge, T. Attina, C.M. Spickett, and D.J. Webb A high-fat meal induces low-grade endotoxemia: evidence of a novel mechanism of postprandial inflammation Am. J. Clin. Nutr. 86 2007 1286 1292
61. A.L. Harte, M.C. Varma, G. Tripathi, K.C. McGee, N.M. Al-Daghri, O.S. Al-Attas, S. Sabico, J.P. O'Hare, A. Ceriello, and P. Saravanan High fat intake leads to acute postprandial exposure to circulating endotoxin in type 2 diabetic subjects Diabetes Care 35 2012 375 382
62. R. Deopurkar, H. Ghanim, J. Friedman, S. Abuaysheh, C.L. Sia, P. Mohanty, P. Viswanathan, A. Chaudhuri, and P. Dandona Differential effects of cream, glucose, and orange juice on inflammation, endotoxin, and the expression of toll-like receptor-4 and suppressor of cytokine signaling-3 Diabetes Care 33 2010 991 997
63. H. Ghanim, C.L. Sia, M. Upadhyay, K. Korzeniewski, P. Viswanathan, S. Abuaysheh, P. Mohanty, and P. Dandona Orange juice neutralizes the proinflammatory effect of a high-fat, high-carbohydrate meal and prevents endotoxin increase and toll-like receptor expression Am. J. Clin. Nutr. 91 2010 940 949
64. A.S. Anderson, K.R. Haynie, R.P. McMillan, K.L. Osterberg, N.E. Boutagy, M.I. Frisard, B.M. Davy, K.P. Davy, and M.W. Hulver Early skeletal muscle adaptations to short-term high-fat diet in humans before changes in insulin sensitivity Obesity 23 2015 4
65. F. Laugerette, C. Vors, A. Géloën, M.-A. Chauvin, C. Soulage, S. Lambert-Porcheron, N. Peretti, M. Alligier, R. Burcelin, and M. Laville Emulsified lipids increase endotoxemia: possible role in early postprandial low-grade inflammation J. Nutr. Biochem. 22 2011 53 59
66. C.J. Hulston, A.A. Churnside, and M.C. Venables Probiotic supplementation prevents high-fat, overfeeding-induced insulin resistance in human subjects Br. J. Nutr. 113 2015 596 602
67. S. Pendyala, J.M. Walker, and P.R. Holt A high-fat diet is associated with endotoxemia that originates from the gut Gastroenterology 142 2012 1100 1101 e1102
68. F. Laugerette, M. Alligier, J.P. Bastard, J. Drai, E. Chanséaume, S. Lambert-Porcheron, M. Laville, B. Morio, H. Vidal, and M.C. Michalski Overfeeding increases postprandial endotoxemia in men: inflammatory outcome may depend on lps transporters lbp and scd14 Mol. Nutr. Food Res. 58 2014 1513 1518
69. P.J. Pussinen, A.S. Havulinna, M. Lehto, J. Sundvall, and V. Salomaa Endotoxemia is associated with an increased risk of incident diabetes Diabetes Care 34 2011 392 397
70. X. Liu, L. Lu, P. Yao, Y. Ma, F. Wang, Q. Jin, X. Ye, H. Li, F.B. Hu, and L. Sun Lipopolysaccharide binding protein, obesity status and incidence of metabolic syndrome: A prospective study among middle-aged and older chinese Diabetologia 57 2014 1834 1841
71. P.N. Patel, R.Y. Shah, J.F. Ferguson, and M.P. Reilly Human experimental endotoxemia in modeling the pathophysiology, genomics, and therapeutics of innate immunity in complex cardiometabolic diseases Arteriosclerosis, Thrombosis, Vasc. Biol. 3 2014 525 534
72. N.N. Mehta, S.P. Heffron, P.N. Patel, J. Ferguson, R.D. Shah, C.C. Hinkle, P. Krishnamoorthy, R. Shah, J. Tabita-Martinez, and K. Terembula A human model of inflammatory cardio-metabolic dysfunction; a double blind placebo-controlled crossover trial J. Transl. Med. 10 2012 124
73. M.R. Rickels, A. Naji, and K.L. Teff Insulin sensitivity, glucose effectiveness, and free fatty acid dynamics after human islet transplantation for type 1 diabetes J. Clin. Endocrinol. Metabolism 91 2006 2138 2144
74. S.M. Haffner, H. Miettinen, and M.P. Stern The homeostasis model in the san antonio heart study Diabetes Care 20 1997 1087 1092
75. M. Buhl, E. Bosnjak, M.H. Vendelbo, J. Gjedsted, R.R. Nielsen, T. K.-Hafstrøm, E.T. Vestergaard, N. Jessen, E. Tønnesen, and A.B. Møller Direct effects of locally administered lipopolysaccharide on glucose, lipid, and protein metabolism in the placebo-controlled, bilaterally infused human leg J. Clin. Endocrinol. Metabolism 98 2013 2090 2099
76. K. Kamisoglu, K.E. Sleight, S.E. Calvano, S.M. Coyle, S.A. Corbett, and I.P. Androulakis Temporal metabolic profiling of plasma during endotoxemia in humans Shock (Augusta, Ga.) 40 2013 519
77. L.C. Hudgins, T.S. Parker, D.M. Levine, B.R. Gordon, S.D. Saal, Jiang X-c, C.E. Seidman, J.D. Tremaroli, J. Lai, and A.L. Rubin A single intravenous dose of endotoxin rapidly alters serum lipoproteins and lipid transfer proteins in normal volunteers J. Lipid Res. 44 2003 1489 1498
78. M. Roden, T.B. Price, G. Perseghin, K.F. Petersen, D.L. Rothman, G.W. Cline, and G.I. Shulman Mechanism of free fatty acid-induced insulin resistance in humans J. Clin. Investigation 97 1996 2859
79. L. Hue, and H. Taegtmeyer The randle cycle revisited: A new head for an old hat Am. J. Physiology-Endocrinology Metabolism 297 2009 E578 E591
80. N.J. Vogelzang Continuous infusion chemotherapy: a critical review J. Clin. Oncol. 2 1984 1289 1304
81. A. Draisma, P. Pickkers, M.P. Bouw, and J.G. van der Hoeven Development of endotoxin tolerance in humans in vivo Crit. Care Med. 37 2009 1261 1267
82. J.-P. Furet, L.-C. Kong, J. Tap, C. Poitou, A. Basdevant, J.-L. Bouillot, D. Mariat, G. Corthier, J. Doré, and C. Henegar Differential adaptation of human gut microbiota to bariatric surgery-induced weight loss links with metabolic and low-grade inflammation markers Diabetes 59 2010 3049 3057
83. S. Ortiz, P. Zapater, J.L. Estrada, P. Enriquez, M. Rey, Á. Abad, J. Such, F. Lluis, and R. Francés Bacterial DNA translocation holds increased insulin resistance and systemic inflammatory levels in morbid obese patients J. Clin. Endocrinol. Metabolism 99 2014 2575 2583
84. P. Dehghan, B.P. Gargari, and M.A. Jafar-Abadi Oligofructose-enriched inulin improves some inflammatory markers and metabolic endotoxemia in women with type 2 diabetes mellitus: A randomized controlled clinical trial Nutrition 30 2014 418 423
85. E.M. Dewulf, P.D. Cani, S.P. Claus, S. Fuentes, P.G. Puylaert, A.M. Neyrinck, L.B. Bindels, W.M. de Vos, G.R. Gibson, and J.-P. Thissen Insight into the prebiotic concept: lessons from an exploratory, double blind intervention study with inulin-type fructans in obese women Gut 8 2012 1112 1121
86. A. Dixon, G. Valsamakis, M. Hanif, A. Field, A. Boutsiadis, A. Harte, P.G. McTernan, A.H. Barnett, and S. Kumar Effect of the orlistat on serum endotoxin lipopolysaccharide and adipocytokines in South Asian individuals with impaired glucose tolerance Int. J. Clin. Pract. 62 2008 1124 1129
87. F.S. Lira, J.C. Rosa, G.D. Pimentel, R.V. Santos, J. Carnier, P.L. Sanches, A. de Piano, C.T. de Souza, L. Tock, and S. Tufik Long-term interdisciplinary therapy reduces endotoxin level and insulin resistance in obese adolescents Nutr. J. 18 2012 74
88. S. Xiao, N. Fei, X. Pang, J. Shen, L. Wang, B. Zhang, M. Zhang, X. Zhang, C. Zhang, and M. Li A gut microbiota-targeted dietary intervention for amelioration of chronic inflammation underlying metabolic syndrome FEMS Microbiol. Ecol. 87 2014 357 367
89. J.-M. Lecerf, F. Dépeint, E. Clerc, Y. Dugenet, C.N. Niamba, L. Rhazi, A. Cayzeele, G. Abdelnour, A. Jaruga, and H. Younes Xylo-oligosaccharide (xos) in combination with inulin modulates both the intestinal environment and immune status in healthy subjects, while xos alone only shows prebiotic properties Br. J. Nutr. 108 2012 1847 1858
90. A. Das, P. Kumar, and S. Swain Recent advances in biosensor based endotoxin detection Biosens. Bioelectron. 51 2014 62 75
91. T.J. Novitsky Limitations of the limulus amebocyte lysate test in demonstrating circulating lipopolysaccharides Ann. N. Y. Acad. Sci. 851 1998 416 421
92. M. Dawson, T. Novitsky, and M. Gould Microbes, endotoxins and water Pharm. Eng. 8 1988 145 148
93. T. Morita, T. Nakamura, T. Miyata, and S. Iwanaga Biochemical characterization of limulus clotting factors and inhibitors which interact with bacterial endotoxins Prog. Clin. Biological Res. 189 1985 53 66
94. J.D. Sullivan Jr., and S.W. Watson Inhibitory effect of heparin on the limulus test for endotoxin J. Clin. Microbiol. 2 1976 151
95. J. Cohen, and J.S. McConnell Observations on the measurement and evaluation of endotoxemia by a quantitative limulus lysate microassay J. Infect. Dis. 150 1984 916 924
96. B. Ditter, K.P. Becker, R. Urbaschek, and B. Urbaschek Detection of endotoxin in blood and other specimens by evaluation of photometrically registered lal-reaction-kinetics in microtiter plates Prog. Clin. Biol. Res. 93 1982 385 392
97. T.J. Novitsky, and P.F. Roslansky Quantification of endotoxin inhibition in serum and plasma using a turbidimetric lal assay Prog. Clin. Biol. Res. 189 1985 181 196
98. J.L. Ding, and B. Ho A new era in pyrogen testing TRENDS Biotechnol. 19 2001 277 281
99. M. Dawson Interference with the lal test and how to address it LAL Update 22 2005 1 5
100. T. Novitsky Limulus amebocyte lysate (lal) detection of endotoxin in human blood J. Endotoxin Res. 1 1994 253 263
101. R.S. Munford Invited review: detoxifying endotoxin: time, place and person J. Endotoxin Res. 11 2005 69 84
102. Z. Nadhazi, A. Takats, K. Offenmuller, and L. Bertok Plasma endotoxin level of healthy donors Acta Microbiol. Immunol. Hung. 49 2002 151 157
103. O.S. Al-Attas, N.M. Al-Daghri, K. Al-Rubeaan, N.F. da Silva, S.L. Sabico, S. Kumar, P.G. McTernan, and A.L. Harte Changes in endotoxin levels in t2dm subjects on anti-diabetic therapies Cardiovasc. Diabetol. 8 2009 20
104. M. Yaroustovsky, M. Plyushch, D. Popov, N. Samsonova, M. Abramyan, Z. Popok, and N. Krotenko Prognostic value of endotoxin activity assay in patients with severe sepsis after cardiac surgery J. Inflamm. (London, England) 10 2013 8
105. M. Malaguarnera, M. Vacante, T. Antic, M. Giordano, G. Chisari, R. Acquaviva, S. Mastrojeni, G. Malaguarnera, A. Mistretta, and G.L. Volti Bifidobacterium longum with fructo-oligosaccharides in patients with non alcoholic steatohepatitis Dig. Dis. Sci. 57 2012 545 553